| Serial Number | 90672384 |
| Word Mark | TYCRUVA |
| Filing Date | Monday, April 26, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 2, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 3, 2023 |
| Description of Mark | The mark consists of the word "TYCRUVA" in stylized font with curved lines above and below the letters "TYC". |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 23, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Monday, October 2, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, October 2, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, February 28, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 3, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 3, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 14, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 23, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 23, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, November 23, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 23, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 23, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, May 3, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, May 3, 2022 | FINAL REFUSAL E-MAILED |
| Tuesday, May 3, 2022 | FINAL REFUSAL WRITTEN |
| Wednesday, April 6, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 6, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 6, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 8, 2021 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Friday, October 8, 2021 | PRIORITY ACTION E-MAILED |
| Friday, October 8, 2021 | PRIORITY ACTION WRITTEN |
| Tuesday, October 5, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, August 3, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, July 31, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 29, 2021 | NEW APPLICATION ENTERED |